Patents by Inventor Venkata VOLETI

Venkata VOLETI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20240115506
    Abstract: The invention relates to solid pharmaceutical dosage forms comprising an extended release core comprising metformin hydrochloride and one or two immediate release coatings comprising linagliptin and/or empagliflozin.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 11, 2024
    Inventors: Georg BOECK, Kerstin Julia SCHAEFER, Venkata VOLETI, Tracy KENNA
  • PHARMACEUTICAL COMPOSITION AND USES THEREOF
    Publication number: 20220287980
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: June 3, 2022
    Publication date: September 15, 2022
    Inventors: Masanori ITO, Kenji EGUSA, Kyle KLEINBECK, Roman MESSERSCHMID, Peter SCHNEIDER, Venkata VOLETI
  • PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20220105043
    Abstract: The invention relates to solid pharmaceutical dosage forms comprising an extended release core comprising metformin hydrochloride and one or two immediate release coatings comprising linagliptin and/or empagliflozin.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Inventors: Georg BOECK, Kerstin Julia FRANK, Venkata VOLETI, Tracy WILLIAMSON
  • PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20180344647
    Abstract: The invention relates to solid pharmaceutical dosage forms comprising an extended release core comprising metformin hydrochloride and one or two immediate release coatings comprising linagliptin and/or empagliflozin.
    Type: Application
    Filed: December 1, 2016
    Publication date: December 6, 2018
    Inventors: Georg BOECK, Kerstin Julia FRANK, Venkata VOLETI, Tracy WILLIAMSON
  • PHARMACEUTICAL COMPOSITION AND USES THEREOF
    Publication number: 20170095424
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: December 15, 2016
    Publication date: April 6, 2017
    Inventors: Masanori ITO, Kenji EGUSA, Kyle KLEINBECK, Roman MESSERSCHMID, Peter SCHNEIDER, Venkata VOLETI
  • Pharmaceutical composition and uses thereof
    Patent number: 9555001
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: January 31, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Masanori Ito, Kenji Egusa, Kyle Kleinbeck, Roman Messerschmid, Peter Schneider, Venkata Voleti
  • PHARMACEUTICAL COMPOSITION AND USES THEREOF
    Publication number: 20160106677
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and metformin XR (extended release), processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: October 16, 2015
    Publication date: April 21, 2016
    Inventors: Georg BOECK, Venkata VOLETI, Tracy WILLIAMSON
  • PHARMACEUTICAL COMPOSITION AND USES THEREOF
    Publication number: 20130236543
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: March 5, 2013
    Publication date: September 12, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Masanori ITO, Kenji EGUSA, Kyle KLEINBECK, Roman MESSERSCHMID, Peter SCHNEIDER, Venkata VOLETI